MiRNAs as non-invasive biomarkers for lung cancer diagnosis

Molecules

Volumn 19, Issue 6, 2014, Pages 8220-8237

  Ulivi, Paola ^a   Zoli, Wainer ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

Diagnosis; MiRNAs; Non invasive biomarker; NSCLC

Indexed keywords

MICRORNA; TUMOR MARKER;

GENETICS; HUMAN; LUNG NEOPLASMS;

HUMANS; LUNG NEOPLASMS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 84903289253     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19068220     Document Type: Review

References (89)

1. National Lung Screening Trial Research Team; Aberle D.R.; Berg C.D.; Black W.C.; Church T.R.; Fagerstrom R.M.; Galen B.; Gareen I.F.; Gatsonis C. ; Goldin J.; et al. The National Lung Screening Trial: Overview and Study Design. Radiology 2011 258 243-253.
2. Jemal A.; Siegel R.; Xu J.; Ward E. Cancer Statistics 2010. CA Cancer. J. Clin. 2010 60 277-300.
3. Ulivi P.; Silvestrini R. Role of Quantitative and Qualitative Characteristics of Free Circulating DNA in the Management of Patients with Non-Small Cell Lung Cancer. Cell. Oncol. (Do rdr) 2013 36 439-448.
4. Sozzi G.; Boeri M.; Rossi M.; Verri C.; Suatoni P.; Bravi F.; Roz L.; Conte D.; Grassi M.; Sverzellati N.; et al. Clinical Utility of a Plasma-Based miRNA Signature Classifier within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study. J. Clin. Oncol. 2014 doi:10.1200/JCO.2013.50.4357.
5. Markopoulou S.; Nikolaidis G.; Lil oglou T. DNA Methylation Biomarkers in Biological Fluids for Early Detection of Respiratory Tract Cancer. Clin. Chem. Lab. Med. 2012 50 1723-1731.
6. Fleischhacker M.; Dietrich D.; Liebenberg V.; Field J.K.; Schmidt B. The Role of DNA Methylation as Biomarkers in the Clinical Management of Lung Cancer. Expert Rev. Respir. Med. 2013 7 363-38 3.
7. Ulivi P.; Mercatali L.; Casoni G.L.; Scarpi E.; Bucchi L.; Silvestrini R.; Sanna S.; Monteverde M.; Amadori D.; Poletti V.; et al. Multiple Marker Detection in Peripheral B lood for NSCLC Diagnosis. PLoS One 2013 8 e57401.
8. Quintans J.S.; Antoniolli A.R.; Onofre F.M.; Onofre A.S. Detection of Lung Cancer using Multiple Genetic Markers-A Systematic Review. Diagn. Cytopathol. 2013 41 834-842.
9. Andriani F.; Conte D.; Mastrangelo T.; Leon M.; Ratcliffe C.; Roz L.; Pelosi G.; Goldstraw P.; Sozzi G.; Pastorino U. Detecti ng Lung Cancer in Plasma with the use of Multiple Genetic Markers. Int. J. Cancer 2004 108 91-96.
10. Redova M.; Sana J.; Slaby O. Circulating miRNAs as New Blood-Based Biomarkers for Solid Cancers. Future Oncol. 2013 9 387-402.
11. Chen X.; Ba Y.; Ma L.; Cai X.; Yin Y.; Wang K.; Guo J.; Zhang Y.; Chen J.; Guo X.; et al. Characterization of micro RNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases. Cell Res. 2008 18 997-1006.
12. Bartel D.P. MicroRNAs: Genomics Biogenesis Mechanism and Function. Cell 2004 116 281-297.
13. Ambros V. The Functions of Animal microRNAs. Nature 2004 431 350-355.
14. Krol J.; Loedige I.; Filipowicz W. The Widespread Regulation of microRNA Biogenesis Function and Decay. Nat. Rev. Genet. 2010 11 597-610.
15. Garzon R.; Marcucci G.; Croce C.M. Targeting microRNAs in Cancer: Rationale Strategies and Challenges. Nat. Rev. Drug Discov. 2010 9 775-789.
16. Kasinski A.L.; Slack F.J. Epigenetics and Genetics. MicroRNAs En Route to the Clinic: Progress in Validating and Targeting microRNAs for Cancer Therapy. Nat. Rev. Cancer 2011 11 849-864.
17. Lin P.Y. Yu S.L. Yang P.C. MicroRNA in Lung Cancer Br. J. Cancer 2010 103 1144-1148.
18. Murak ami Y.; Yasuda T.; Saigo K.; Urashima T.; Toyoda H.; Okanoue T.; Shimotohno K. Comprehensive Analysis of microRNA Expression Patterns in Hepatocellular Carcinoma and Non-Tumorous Tissues. Oncogene 2006 25 2537-2545.
19. Iorio M.V.; Ferracin M.; Liu C.G.; Veronese A.; Spizzo R.; Sabbioni S.; Magri E.; Pedriali M.; Fabbri M.; Campiglio M.; et al. MicroRNA Gene Expression Der egulation in Human Breast Cancer. Cancer Res. 2005 65 7065-7070.
20. Roldo C.; Missiaglia E.; Hagan J.P.; Falconi M.; Capelli P.; Bersani S.; Calin G.A.; Volinia S.; Liu C.G.; Scarpa A.; et al. MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors are Associated with Distinctive Pathologic Features and Clinical Behavior. J. Clin. Oncol. 2006 24 4677-4684.
21. Chen W.; Tang Z.; Sun Y.; Zhang Y.; Wang X.; Shen Z.; Liu F.; Qin X. MiRNA Expression Profile in Primary Gastric Cancers and Paired Lymph Node Metastases Indicates that miR-10a Plays a Role in Metastas is from Primary Gastric Cancer to Lymph Nodes. Exp. Ther. Med. 2012 3 351-356.
22. Porkka K.P.; Pfeiffer M.J.; Waltering K.K.; Vessella R.L.; Tammela T.L.; Visakorpi T. MicroRNA Expre ssion Profiling in Prostate Cancer. Cancer Res. 2007 67 6130-6135.
23. Wang Q.; Wang S.; Wang H.; Li P.; Ma Z. MicroRNAs: Novel Biomarkers for Lung Cancer Diagnosis Prediction an d Treatment. Exp. Biol. Med. (Maywood) 2012 237 227-235.
24. Madhavan D.; Cuk K.; Burwinkel B.; Yang R. Cancer Diagnosis and Prognosis Decoded by Blood-Based Circulating microRNA Signatures. Front. Genet. 2013 4 116.
25. Lawrie C.H.; Gal S.; Dunlop H.M.; Pushkaran B.; Liggins A.P.; Pulford K.; Banham A.H.; Pezzella F.; Boultwood J.; Wainscoat J.S.; et al. Detection of Elevated Levels of Tumour-Associated microRNAs in Serum of Patients with Diffuse Large B-Cell Lymphoma. Br. J. Haematol. 2008 141 672-675.
26. Mitchell P.S.; Parkin R.K.; Kroh E.M.; Fritz B.R.; Wyman S.K.; Pogosova-Agadjanyan E.L.; Peterson A.; Noteboom J.; O'Briant K.C.; Allen A.; et al. Circulating microRNAs as Stable Blood-Based Markers for Cancer Detection. Proc. Natl. Acad. Sci. USA 2008 105 10513-10518.
27. Zen K.; Zhang C.Y. Circulating microRNAs: A Novel Class of Biomarkers to Diagnose and Monitor Human Cancers. Med. Res. Rev. 2012 32 326-348.
28. Fevrier B.; Raposo G. Exosomes: Endosomal-Derived Vesicles Shipping Extracellular Messages. Curr. Opin. Cell Biol. 2004 16 415-421.
29. Lodes M.J.; Caraballo M.; Suciu D.; Munro S.; Kumar A.; Anderson B. Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLoS One 2009 4 e6229.
30. Gutw ein P.; Stoeck A.; Riedle S.; Gast D.; Runz S.; Condon T.P.; Marme A.; Phong M.C.; Linderkamp O.; Skorokhod A.; et al. Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells. Clin. Cancer Res. 2005 11 2492-2501.
31. Vickers K.C.; Palmisano B.T.; Shoucri B.M.; Shamburek R.D.; Remaley A.T. MicroRNAs are Transported in Plasma and Delivered to Recipi ent Cells by High-Density Lipoproteins. Nat. Cell Biol. 2011 13 423-433.
32. Arroyo J.D.; Chevillet J.R.; Kroh E.M.; Ruf I.K.; Pritchard C.C.; Gibson D.F.; Mitchell P.S.; Bennett C.F.; Pogosova-Agadjanyan E.L.; Stirewalt D.L.; et al. Argonaute2 Complexes Carry a Population of Circulating microRNAs Independent of Vesicles in Human Plasma. Proc. Natl. Acad. Sci. USA 2011 108 5003-5008.
33. Li J.; Smyth P.; Flavin R.; Cahill S.; Denning K.; Aherne S.; Guenther S.M.; O'Leary J.J.; Sheils O. Comparison of miRNA Expression Patterns using Total RNA Extracted from Matched Samples of F ormalin-Fixed Paraffin-Embedded (FFPE) Cells and Snap Frozen Cells. BMC Biotechnol. 2007 7 36.
34. Park N.J.; Zhou H.; Elashoff D.; Henson B.S.; Kastratovic D.A.; Abemayor E.; Wong D.T. Salivary microRNA: Disc overy Characterization and Clinical Utility for Oral Cancer Detection. Clin. Cancer Res. 2009 15 5473-5477.
35. Gilad S.; Meiri E.; Yogev Y.; Benjamin S.; Lebanony D.; Yerushalmi N.; Benjamin H.; Kushnir M.; Cholakh H.; Melamed N.; et al. Serum microRNAs are Promising Novel Biomarkers. PLoS One 2008 3 e3148.
36. Valadi H.; Ekstrom K.; Bossios A.; Sjos trand M.; Lee J.J.; Lotvall J.O. Exosome-Mediated Transfer of mRNAs and microRNAs is a Novel Mechanism of Genetic Exchange between Cells. Nat. Cell Biol. 2007 9 654-659.
37. Collino F.; Deregibu s M.C.; Bruno S.; Sterpone L.; Aghemo G.; Viltono L.; Tetta C.; Camussi G. Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs. PLoS One 2010 5 e11803.
38. Zernecke A. Bidzhekov K. Noels H. Shagdarsuren E. Gan L. Denecke B. Hristov M. Koppel T. Jahantigh M.N. Lutgens E. et alDelivery of microRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection. Sci. Signal. 20091 2 ra81.
39. Bye A.; Rosjo H.; Aspenes S.T.; Condorelli G.; Omland T.; Wisloff U. Circulating microRNAs and Aerobic Fitness-The HUNT-Study. PLoS One 2013 8 e57496.
40. Ai J.; Zhang R.; Li Y.; Pu J.; Lu Y.; Jiao J.; Li K.; Yu B.; Li Z.; Wang R.; et al. Circulating microRNA-1 as a Potential Novel Biomarker for Acute Myocardial Infarction. Biochem. B iophys. Res. Commun. 2010 391 73-77.
41. Tijsen A.J.; Creemers E.E.; Moerland P.D.; de Windt L.J.; van der Wal A.C.; Kok W.E.; Pinto Y.M. MiR423-5p as a Circulating Biomarker for Heart Failure. Circ. Res. 2010 106 1035-1039.
42. Ji X.; Takahashi R.; Hiura Y.; Hirokawa G.; Fukushima Y.; Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin. Chem. 2009 55 1944-1949.
43. Haider B.A.; Baras A.S.; McCall M.N.; Hertel J.A.; Cornish T.C.; Halushka M.K. A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease. PLoS On e 2014 9 e89565.
44. Qi Y.; Zhu Z.; Shi Z.; Ge Y.; Zhao K.; Zhou M.; Cui L. Dysregulated microRNA Expression in Serum of Non-Vaccinated Children with Varicella. Viruses 2014 6 1823-1836.
45. Zhu Z.; Qi Y.; Ge A.; Zhu Y.; Xu K.; Ji H.; Shi Z.; Cui L.; Zhou M. Comprehensive Characterization of Serum MicroRNA Profile in Response to the Em erging Avian Influenza A (H7N9) Virus Infection in Humans. Viruses 2014 6 1525-1539.
46. Chen Q.; Si Q.; Xiao S.; Xie Q.; Lin J.; Wang C.; Chen L.; Chen Q.; Wang L. Prognostic Significance of Serum miR-17-5p in Lung Cancer. Med. Oncol. 2013 30 353.
47. Volinia S.; Calin G.A.; Liu C.G.; Ambs S.; Cimmino A.; Petrocca F.; Visone R.; Iorio M.; Roldo C.; Ferracin M.; et al. A microRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets. Proc. Natl. Acad. Sci. USA 2006 103 2257-2261.
48. Lu J.; Getz G.; Miska E.A.; Alvarez-Saavedra E.; Lamb J.; Peck D.; Sweet-Cordero A.; Ebert B.L.; Mak R .H.; Ferrando A.A.; et al. MicroRNA Expression Profiles Classify Human Cancers. Nature 2005 435 834-838.
49. Lowery A.J.; Miller N.; McNeill R.E.; Kerin M.J. MicroRNAs as Prog nostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management. Clin. Cancer Res. 2008 14 360-365.
50. Coulouarn C.; Factor V.M.; Andersen J.B.; Durkin M.E.; Thorgeirsson S.S. Loss of miR-122 Expression in Liver Cancer Correlates with Suppression of the Hepatic Phenotype and Gain of Metastatic Properties. Oncogene 2009 28 3526-3536.
51. Xu J.; Wu C.; Che X.; Wang L.; Yu D.; Zhang T.; Huang L.; Li H.; Tan W.; Wang C.; et al. Circulating microRNAs miR-21 miR-122 and miR-223 in Patients with Hepatocellular Carcinoma Or Chronic Hepatitis. Mol. Carcinog. 2011 50 136-142.
52. Hennessey P.T.; Sanford T.; Choudhary A.; Mydlarz W.W.; Brown D.; Adai A.T.; Ochs M.F.; Ahrendt S.A.; Mambo E.; Califano J.A. Serum microRNA Biomarkers for D etection of Non-Small Cell Lung Cancer. PLoS One 2012 7 e32307.
53. Bianchi F.; Nicassio F.; Marzi M.; Belloni E.; Dall'olio V.; Bernard L.; Pelosi G.; Maisonneuve P.; V eronesi G.; di Fiore P.P. A Serum Circulating miRNA Diagnostic Test to Identify Asymptomatic High-Risk Individuals with Early Stage Lung Cancer. EMBO Mol. Med. 2011 3 495-503.
54. Keller A.; Leidinger P.; Gislefoss R.; Haugen A.; Langseth H.; Staehler P.; Lenhof H.P.; Meese E. Stable Serum miRNA Profiles as Potential Tool for Non-Invasive Lung Cancer Diagnosis. RNA Bi ol. 2011 8 506-516.
55. Chen X.; Hu Z.; Wang W.; Ba Y.; Ma L.; Zhang C.; Wang C.; Ren Z.; Zhao Y.; Wu S.; et al. Identification of Ten Serum microRNAs from a G enome-Wide Serum microRNA Expression Profile as Novel Noninvasive Biomarkers for Nonsmall Cell Lung Cancer Diagnosis. Int. J. Cancer 2012 130 1620-1628.
56. Foss K.M.; Sima C.; Ugolini D.; Neri M.; Allen K.E.; Weiss G.J. MiR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-Small Cell Lung Cancer. J. Thorac. Oncol. 2011 6 482-488.
57. Rani S.; Gately K.; C rown J.; O'Byrne K.; O'Driscoll L. Global Analysis of Serum microRNAs as Potential Biomarkers for Lung Adenocarcinoma. Cancer. Biol. Ther. 2013 14 1104-1112.
58. Roth C.; Stuckrath I.; Pantel K.; Izbicki J.R.; Tachezy M.; Schwarzenbach H. Low Levels of Cell-Free Circulating miR-361-3p and miR-625 as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors. PLoS One 2012 7 e38248.
59. Le H.B.; Zhu W.Y.; Chen D.D.; He J.Y.; Huang Y.Y.; Liu X.G.; Zhang Y.K. Evaluation of Dynamic Change of Serum miR-21 and miR-24 in Pre-and Post-Operative Lung Carcinoma Patients. Med. Oncol. 2012 29 3190-3197.
60. Yuxia M. Zhennan T. Wei Z Circulating miR-125b is a Novel Biomarker for Screening Non-Small-Cell Lung Cancer and Predicts Poor Prognosis. J. Cancer Res. Clin. Oncol. 2012 138 2045-2050.
61. Zheng D.; Haddadin S.; Wang Y.; Gu L.Q.; Perry M.C.; Freter C.E.; Wang M.X. Plasma microRNAs as Novel Biomarkers for Early Detection of Lung Cancer. Int. J. Clin. E xp. Pathol. 2011 4 575-586.
62. Shen J.; Liu Z.; Todd N.W.; Zhang H.; Liao J.; Yu L.; Guarnera M.A.; Li R.; Cai L.; Zhan M.; et al. Diagnosis of Lung Cancer in Individuals with Solitary Pulmonary Nodules by Plasma microRNA Biomarkers. BMC Cancer 2011 11 374.
63. Shen J.; Todd N.W.; Zhang H.; Yu L.; Lingxiao X.; Mei Y.; Guarnera M.; Liao J.; Chou A.; Lu C.L.; et al. Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer. Lab. Invest. 2011 91 579-587.
64. Silva J.; Garcia V.; Zaballos A.; Pro vencio M.; Lombardia L.; Almonacid L.; Garcia J.M.; Dominguez G.; Pena C.; Diaz R.; et al. Vesicle-Related microRNAs in Plasma of Nonsmall Cell Lung Cancer Patients and Correlation with Survival. Eur. Respir. J. 2011 37 617-623.
65. Tang D.; Shen Y.; Wang M.; Yang R.; Wang Z.; Sui A.; Jiao W.; Wang Y. Identification of Plasma microRNAs as Novel Noninvasive Biomarkers for Early Detection of Lung Cancer. Eur. J. Cancer Prev. 2013 22 540-548.
66. Mozzoni P.; Banda I.; Goldoni M.; Corradi M.; Tiseo M.; Acampa O.; Balestra V.; Ampollini L.; Casalini A.; Car bognani P.; et al. Plasma and EBC microRNAs as Early Biomarkers of Non-Small-Cell Lung Cancer. Biomarkers 2013 18 679-686.
67. Boeri M.; Verri C.; Conte D.; Roz L.; Modena P.; Facchinetti F.; Calabro E.; Croce C.M.; Pastorino U.; Sozzi G. MicroRNA Signatures in Tissues and Plasma Predict Development and Prognosis of Computed Tomography Detected Lung Cancer. Proc. Natl. Acad. Sci. USA 2011 108 3713-3718.
68. Wei J.; Gao W.; Zhu C.J.; Liu Y.Q.; Mei Z.; Cheng T.; Shu Y.Q. Identification of Plasma microRNA-21 as a Biomarker for Early Detection and Chemosensitivity of Non-Small Cell Lung Cancer. Chin. J. Cancer 2011 30 407-414.
69. Lin Q.; Mao W.; Shu Y.; Lin F.; Liu S.; Shen H.; Gao W.; Li S.; Shen D. A Cluster of Specified microRNAs in Peripheral Blood as Biomarkers for Metastatic Non-Small-Cell Lung Cancer by Stem-Loop RT-PCR. J. Cancer Res. Clin. Oncol. 2012 138 85-93.
70. Heegaard N.H.; Schetter A.J.; Welsh J.A.; Yoneda M.; Bowman E.D.; Harris C.C. Circulating Micro-RNA Expression Profiles in Early Stage Nonsmall Cell Lung Cancer. Int. J. Cancer 2012 130 1378-1386.
71. Ma J.; Li N.; Guarnera M.; Jiang F. Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis. Biomark. Insights 2013 8 127-136.
72. Jeong H.C.; Kim E.K.; Lee J.H.; Lee J.M.; Yoo H.N.; Kim J.K. Aberrant Expression of Let-7a miR NA in the Blood of Non-Small Cell Lung Cancer Patients. Mol. Med. Rep. 2011 4 383-387.
73. Showe M.K.; Vachani A.; Kossenkov A.V.; Yousef M.; Nichols C.; Nikonova E.V.; Chang C.; Kucharczuk J.; Tran B.; Wakeam E. et al. Gene Expression Profiles in Peripheral Blood Mononuclear Cells can Distinguish Patients with Non-Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease. Cancer Res. 2009 69 9202-9210.
74. Keller A.; Leidinger P.; Borries A.; Wendschlag A.; Wucherpfennig F.; Scheffler M.; Huwer H.; Lenhof H.P.; Meese E. MiRNAs in Lung Cancer-Studying Complex Fin gerprints in Patient's Blood Cells by Microarray Experiments. BMC Cancer 2009 9 353.
75. Leidinger P.; Keller A.; Borries A.; Huwer H.; Rohling M.; Huebers J.; Lenhof H.P.; Me ese E. Specific Peripheral miRNA Profiles for Distinguishing Lung Cancer from COPD. Lung Cancer 2011 74 41-47.
76. Patnaik S.K.; Yendamuri S.; Kannisto E.; Kucharczuk J.C.; Singhal S .; Vachani A. MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma. PLoS One 2012 7 e46045.
77. Ulivi P.; Foschi G.; Mengozzi M.; Scarpi E.; Silvestrini R.; Ama dori D.; Zoli W. Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC. Int. J. Mol. Sci. 2013 14 10332-10342.
78. Zeng X.L.; Zhang S.Y.; Zheng J.F.; Yuan H.; Wang Y. Altered miR-143 and miR-150 Expressions in Peripheral Blood Mononuclear Cells for Diagnosis of Non-Small Cell Lung Cancer. Chin. Med. J. (Engl.) 2013 126 4510-4516.
79. Xie Y.; To dd N.W.; Liu Z.; Zhan M.; Fang H.; Peng H.; Alattar M.; Deepak J.; Stass S.A.; Jiang F. Altered miRNA Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer. Lung Cancer 2010 67 170-176.
80. Yu L.; Todd N.W.; Xing L.; Xie Y.; Zhang H.; Liu Z.; Fang H.; Zhang J.; Katz R.L.; Jiang F. Early Detection of Lung Adenocarcinoma in Sputum by a Panel of microRNA Mar kers. Int. J. Cancer 2010 127 2870-2878.
81. Xing L. Todd N.W. Yu L. Fang H. Jiang F Early Detection of Squamous Cell Lung Cancer in Sputum by a Panel of microRNA Markers. Mod. Pathol. 2010 23 1157-1164.
82. Roa W.H.; Kim J.O.; Razzak R.; Du H.; Guo L.; Singh R.; Gazala S.; Ghosh S.; Wong E.; Joy A.A.; et al. Sputum microRNA Profiling: A Novel Approach for the Early Detection of Non-Sma ll Cell Lung Cancer. Clin. Invest. Med. 2012 35 E271.
83. Shen J.; Liao J.; Guarnera M.A.; Fang H.; Cai L.; Stass S.A.; Jiang F. Analysis of MicroRNAs in Sputum to Improve Comput ed Tomography for Lung Cancer Diagnosis. J. Thorac. Oncol. 2014 9 33-40.
84. Li N.; Ma J.; Guarnera M.A.; Fang H.; Cai L.; Jiang F. Digital PCR Quantification of miRNAs in Sputum for Diagnosis of Lung Cancer. J. Cancer Res. Clin. Oncol. 2014 140 145-150.
85. Zandberga E.; Kozirovskis V.; Abols A.; Andrejeva D.; Purkalne G.; Line A. Cell-Free microRNAs as Diagnosti c Prognostic and Predictive Biomarkers for Lung Cancer. Genes Chromosomes Cancer 2013 52 356-369.
86. Brase J.C.; Wuttig D.; Kuner R.; Sultmann H. Serum microRNAs as Non-Invasive Biomarkers for Cancer. Mol. Cancer 2010 9 306.
87. Cazzoli R.; Buttitta F.; di Nicola M.; Malatesta S.; Marchetti A.; Rom W.N.; Pass H.I. MicroRNAs Derived from Circulating Exosome s as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. J. Thorac. Oncol. 2013 8 1156-1162.
88. Veronesi G.; Bellomi M.; Mulshine J.L.; Pelosi G.; Scanagatta P.; Paganelli G. ; Maisonneuve P.; Preda L.; Leo F.; Bertolotti R.; et al. Lung Cancer Screening with Low-Dose Computed Tomography: A Non-Invasive Diagnostic Protocol for Baseline Lung Nodules. Lung Cancer 2008 61 340-34 9.
89. Pastorino U.; Rossi M.; Rosato V.; Marchiano A.; Sverzellati N.; Morosi C.; Fabbri A.; Galeone C.; Negri E.; Sozzi G.; et al. Annual Or Biennial CT Screening Versus Observa tion in Heavy Smokers: 5-Year Results of the MILD Trial. Eur. J. Cancer Prev. 2012 21 308-315.